As of 13 June, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18172 deaths.
FDA Warns About Fraudulent Tamiflu
The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as Generic Tamiflu sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu’s active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin.
CDC issues 2009 H1N1 Pandemic: Summary Highlights, April 2009-April 2010
Centers for Disease Control and Prevention document that summarizes key events of the 2009 H1N1 pandemic and CDC’s response activities.
NIH-Funded Scientists Find 2009 H1N1 Pandemic Influenza Vaccine Protects Mice from 1918 Influenza Virus
Mice injected with a 2009 H1N1 pandemic influenza vaccine and then exposed to high levels of the virus responsible for the 1918 influenza pandemic do not get sick or die, report scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
WHO Director-General Statement on Continuation of Pandemic Disease
A global update was provided to the Committee on the pandemic situation, including a particular focus on developments in Africa and the Southern Hemisphere.
Preliminary Results: Surveillance for Guillain-Barre Syndrome After Receipt of Influenza A (H1N1) 2009 Monovalent Vaccine — United States, 2009–2010
Guillain-Barre syndrome (GBS) is an uncommon peripheral neuropathy causing paralysis and in severe cases respiratory failure and death.